Binding Site Information of Target
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T67162 | Target Info | |||
| Target Name | Dopamine D2 receptor (D2R) | ||||
| Synonyms | Dopamine receptor 2; D(2) dopamine receptor | ||||
| Target Type | Successful Target | ||||
| Gene Name | DRD2 | ||||
| Biochemical Class | GPCR rhodopsin | ||||
| UniProt ID | |||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| Ligand Name: Bromocriptine | Ligand Info | |||||
| Structure Description | Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane | PDB:6VMS | ||||
| Method | Electron microscopy | Resolution | 3.80 Å | Mutation | No | [1] |
| PDB Sequence |
PHYNYYATLL
41 TLLIAVIVFG51 NVLVCMAVSR61 EKALQTTTNY71 LIVSLAVADL81 LVATLVMPWV 91 VYLEVVGEWK101 FSRIHCDIFV111 TLDVMMCTAS121 ILNLCAISID131 RYTAVAMPML 141 YNTRYSSKRR151 VTVMISIVWV161 LSFTISCPLL171 FGLNNADQNE181 CIIANPAFVV 191 YSSIVSFYVP201 FIVILLVYIK211 IYIVLRRRRK221 LVNTNRKLSQ365 QKEKKATQLL 375 AIYLGLFIIC385 WLPFFITHIL395 NIHCDCNIPP405 VLYSAFTWLG415 YVNSAINPII 425 YTTFNIEFRK435 AFLKILHC
|
|||||
|
|
LEU94
4.374
PHE110
3.541
VAL111
3.516
ASP114
2.759
VAL115
3.914
CYS118
3.425
THR119
3.464
ILE122
3.417
CYS182
3.298
ILE183
3.790
ILE184
3.505
PHE189
4.963
VAL190
3.623
|
|||||
| Ligand Name: Risperidone | Ligand Info | |||||
| Structure Description | Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidone | PDB:6CM4 | ||||
| Method | X-ray diffraction | Resolution | 2.87 Å | Mutation | No | [2] |
| PDB Sequence |
NYYATLLTLL
44 IAVIVFGNVL54 VCMAVSREKA64 LQTTTNYLIV74 SLAVADLLVA84 TLVMPWVVYL 94 EVVGEWKFSR104 IHCDIFVTLD114 VMMCTASALN124 LCAISIDRYT134 AVAMPTRYSS 148 KRRVTVMISI158 VWVLSFTISC168 PLLFGLNNAD178 QNECIIANPA188 FVVYSSIVSF 198 YVPFIVTLLV208 YIKIYIVLRR218 RRKRNIFEML1007 RIDEGLRLKI1017 YKDTEGYYTI 1027 GIGHLLTKSP1037 SLNAAKSELD1047 KAIGRNTNGV1057 ITKDEAEKLF1067 NQDVDAAVRG 1077 ILRNAKLKPV1087 YDSLDAVRRA1097 ALINMVFQMG1107 ETGVAGFTNS1117 LRMLQQKRWD 1127 EAAVNLAKSR1137 WYNQTPNRAK1147 RVITTFRTGT1157 WDAYSQQKEK369 KATQMAAIVA 379 GVFIICWLPF389 FITHILNIHC399 DCNIPPVLYS409 AFTWLGYVNS419 AVNPIIYTTF 429 NIEFRKAFLK439 ILH
|
|||||
|
|
VAL91
4.442
LEU94
4.082
TRP100
3.497
PHE110
3.744
ASP114
2.694
VAL115
3.803
CYS118
3.334
THR119
3.727
ALA122
3.306
ILE184
4.478
PHE189
4.459
SER193
3.996
|
|||||
| Ligand Name: Haloperidol | Ligand Info | |||||
| Structure Description | Haloperidol bound D2 dopamine receptor structure inspired discovery of subtype selective ligands | PDB:6LUQ | ||||
| Method | X-ray diffraction | Resolution | 3.10 Å | Mutation | No | [3] |
| PDB Sequence |
NYYATLLTLL
44 IAVIVFGNVL54 VCMAVSREKA64 LQTTTNYLIV74 SLAVADLLVA84 TLVMPWVVYL 94 EVVGEWKFSR104 IHCDIFVTLD114 VMMCTASALN124 LCAISIDRYT134 AVAMPTRYSS 148 KRRVTVMISI158 VWVLSFTISC168 PLLFGLNNAD178 QNECIIANPA188 FVVYSSIVSF 198 YVPFIVTLLV208 YIKIYIVLRR218 RRKRNIFEML228 RIDEGLRLKI238 YKDTEGYYTI 248 GIGHLLTKSP258 SLNAAKSELD268 KAIGRNTNGV278 ITKDEAEKLF288 NQDVDAAVRG 298 ILRNAKLKPV308 YDSLDAVRRA318 ALINMVFQMG328 ETGVAGFTNS338 LRMLQQKRWD 348 EAAVNLAKSR358 WYNQTPNRAK368 RVITTFRTGT378 WDAYQKEKKA392 TQMAAIVAGV 402 FIICWLPFFI412 THILNIHCDC422 NIPPVLYSAF432 TWLGYVNSAV442 NPIIYTTFNI 452 EFRKAFLKIL462 H
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GMJ or .GMJ2 or .GMJ3 or :3GMJ;style chemicals stick;color identity;select .A:94 or .A:100 or .A:107 or .A:110 or .A:111 or .A:114 or .A:115 or .A:118 or .A:119 or .A:122 or .A:184 or .A:189 or .A:193 or .A:197 or .A:198 or .A:403 or .A:407 or .A:410 or .A:411 or .A:429 or .A:433 or .A:437; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LEU94
3.426
TRP100
4.761
CYS107
4.036
PHE110
3.259
VAL111
3.770
ASP114
2.337
VAL115
3.936
CYS118
3.554
THR119
4.284
ALA122
3.739
ILE184
3.694
|
|||||
| Ligand Name: Oleic acid | Ligand Info | |||||
| Structure Description | Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidone | PDB:6CM4 | ||||
| Method | X-ray diffraction | Resolution | 2.87 Å | Mutation | No | [2] |
| PDB Sequence |
NYYATLLTLL
44 IAVIVFGNVL54 VCMAVSREKA64 LQTTTNYLIV74 SLAVADLLVA84 TLVMPWVVYL 94 EVVGEWKFSR104 IHCDIFVTLD114 VMMCTASALN124 LCAISIDRYT134 AVAMPTRYSS 148 KRRVTVMISI158 VWVLSFTISC168 PLLFGLNNAD178 QNECIIANPA188 FVVYSSIVSF 198 YVPFIVTLLV208 YIKIYIVLRR218 RRKRNIFEML1007 RIDEGLRLKI1017 YKDTEGYYTI 1027 GIGHLLTKSP1037 SLNAAKSELD1047 KAIGRNTNGV1057 ITKDEAEKLF1067 NQDVDAAVRG 1077 ILRNAKLKPV1087 YDSLDAVRRA1097 ALINMVFQMG1107 ETGVAGFTNS1117 LRMLQQKRWD 1127 EAAVNLAKSR1137 WYNQTPNRAK1147 RVITTFRTGT1157 WDAYSQQKEK369 KATQMAAIVA 379 GVFIICWLPF389 FITHILNIHC399 DCNIPPVLYS409 AFTWLGYVNS419 AVNPIIYTTF 429 NIEFRKAFLK439 ILH
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .OLA or .OLA2 or .OLA3 or :3OLA;style chemicals stick;color identity;select .A:122 or .A:125 or .A:130 or .A:133 or .A:134 or .A:138 or .A:151 or .A:155 or .A:198 or .A:201 or .A:202 or .A:204 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:211 or .A:376 or .A:379 or .A:380 or .A:382 or .A:383; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA122
3.659
LEU125
4.175
ILE130
4.159
TYR133
2.384
THR134
4.368
MET138
4.473
ARG151
3.805
MET155
4.822
PHE198
4.832
PRO201
3.995
PHE202
3.287
VAL204
4.164
|
|||||
| Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane. Nature. 2020 Aug;584(7819):125-129. | ||||
| REF 2 | Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature. 2018 Mar 8;555(7695):269-273. | ||||
| REF 3 | Haloperidol bound D(2) dopamine receptor structure inspired the discovery of subtype selective ligands. Nat Commun. 2020 Feb 26;11(1):1074. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.